Cargando…
Benefits of a Pharmacology Antimalarial Reference Standard and Proficiency Testing Program Provided by the Worldwide Antimalarial Resistance Network (WWARN)
Comprehensive assessment of antimalarial drug resistance should include measurements of antimalarial blood or plasma concentrations in clinical trials and in individual assessments of treatment failure so that true resistance can be differentiated from inadequate drug exposure. Pharmacometric modeli...
Autores principales: | Lourens, Chris, Lindegardh, Niklas, Barnes, Karen I., Guerin, Philippe J., Sibley, Carol H., White, Nicholas J., Tarning, Joel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4068537/ https://www.ncbi.nlm.nih.gov/pubmed/24777099 http://dx.doi.org/10.1128/AAC.02362-14 |
Ejemplares similares
-
Implementation of a reference standard and proficiency testing programme by the World Wide Antimalarial Resistance Network (WWARN)
por: Lourens, Chris, et al.
Publicado: (2010) -
The WWARN Antimalarial Quality Surveyor
por: Tabernero, P, et al.
Publicado: (2012) -
World Antimalarial Resistance Network (WARN) IV: Clinical pharmacology
por: Barnes, Karen I, et al.
Publicado: (2007) -
The power of pooled analysis: WWARN community reaches a critical mass of data
por: Guerin, Philippe J, et al.
Publicado: (2012) -
World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
por: Price, Ric N, et al.
Publicado: (2007)